List of Tables
    Table 1. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Trends
    Table 3. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Drivers
    Table 4. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Challenges
    Table 5. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Restraints
    Table 6. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Paclitaxel and Its Analogue in Anticarcinoma Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs as of 2021)
    Table 15. Top Players of Paclitaxel and Its Analogue in Anticarcinoma Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Paclitaxel and Its Analogue in Anticarcinoma Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Paclitaxel and Its Analogue in Anticarcinoma Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Paclitaxel and Its Analogue in Anticarcinoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bristol-Myers Squibb Company Details
    Table 31. Bristol-Myers Squibb Business Overview
    Table 32. Bristol-Myers Squibb Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 33. Bristol-Myers Squibb Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 34. Bristol-Myers Squibb Recent Development
    Table 35. Celgene Corporation Company Details
    Table 36. Celgene Corporation Business Overview
    Table 37. Celgene Corporation Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 38. Celgene Corporation Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 39. Celgene Corporation Recent Development
    Table 40. Hospira Company Details
    Table 41. Hospira Business Overview
    Table 42. Hospira Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 43. Hospira Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 44. Hospira Recent Development
    Table 45. Biological E. Company Details
    Table 46. Biological E. Business Overview
    Table 47. Biological E. Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 48. Biological E. Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 49. Biological E. Recent Development
    Table 50. Taj Accura Company Details
    Table 51. Taj Accura Business Overview
    Table 52. Taj Accura Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 53. Taj Accura Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 54. Taj Accura Recent Development
    Table 55. Khandelwal Laboratories Company Details
    Table 56. Khandelwal Laboratories Business Overview
    Table 57. Khandelwal Laboratories Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 58. Khandelwal Laboratories Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 59. Khandelwal Laboratories Recent Development
    Table 60. Luye Pharma Company Details
    Table 61. Luye Pharma Business Overview
    Table 62. Luye Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 63. Luye Pharma Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 64. Luye Pharma Recent Development
    Table 65. Beijing Youcare Company Details
    Table 66. Beijing Youcare Business Overview
    Table 67. Beijing Youcare Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 68. Beijing Youcare Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 69. Beijing Youcare Recent Development
    Table 70. Beijing Union Company Details
    Table 71. Beijing Union Business Overview
    Table 72. Beijing Union Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 73. Beijing Union Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 74. Beijing Union Recent Development
    Table 75. Haiyao Company Details
    Table 76. Haiyao Business Overview
    Table 77. Haiyao Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 78. Haiyao Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 79. Haiyao Recent Development
    Table 80. Chuntch Company Details
    Table 81. Chuntch Business Overview
    Table 82. Chuntch Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 83. Chuntch Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 84. Chuntch Recent Development
    Table 85. Hengrui Medicine Company Details
    Table 86. Hengrui Medicine Business Overview
    Table 87. Hengrui Medicine Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 88. Hengrui Medicine Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 89. Hengrui Medicine Recent Development
    Table 90. Sanofi Company Details
    Table 91. Sanofi Business Overview
    Table 92. Sanofi Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 93. Sanofi Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 94. Sanofi Recent Development
    Table 95. Qilu Pharma Company Details
    Table 96. Qilu Pharma Business Overview
    Table 97. Qilu Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 98. Qilu Pharma Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 99. Qilu Pharma Recent Development
    Table 100. Shenzhen Main Luck Pharma Company Details
    Table 101. Shenzhen Main Luck Pharma Business Overview
    Table 102. Shenzhen Main Luck Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 103. Shenzhen Main Luck Pharma Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 104. Shenzhen Main Luck Pharma Recent Development
    Table 105. Jiangsu Aosaikang Pharma Company Details
    Table 106. Jiangsu Aosaikang Pharma Business Overview
    Table 107. Jiangsu Aosaikang Pharma Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 108. Jiangsu Aosaikang Pharma Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 109. Jiangsu Aosaikang Pharma Recent Development
    Table 110. CSPC Pharmaceutical Company Details
    Table 111. CSPC Pharmaceutical Business Overview
    Table 112. CSPC Pharmaceutical Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 113. CSPC Pharmaceutical Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 114. CSPC Pharmaceutical Recent Development
    Table 115. Aosaikang Pharm Company Details
    Table 116. Aosaikang Pharm Business Overview
    Table 117. Aosaikang Pharm Paclitaxel and Its Analogue in Anticarcinoma Drugs Product
    Table 118. Aosaikang Pharm Revenue in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022) & (US$ Million)
    Table 119. Aosaikang Pharm Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Paclitaxel and Its Analogue in Anticarcinoma Drugs Product Picture
    Figure 2. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share in Global 2017-2028
    Figure 7. Paclitaxel and Its Analogue in Anticarcinoma Drugs Report Years Considered
    Figure 8. Product Picture of Paclitaxel
    Figure 9. Product Picture of Docetaxel
    Figure 10. Product Picture of Liposome Paclitaxel
    Figure 11. Product Picture of Protein-bound Paclitaxel
    Figure 12. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Type in 2022 & 2028
    Figure 13. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Type (2017-2028)
    Figure 15. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Type in 2022 & 2028
    Figure 16. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Type (2017-2028)
    Figure 18. Product Picture of Ovarian Cancer
    Figure 19. Product Picture of Breast Cancer
    Figure 20. Product Picture of Cervical Cancer
    Figure 21. Product Picture of Pancreatic Cancer
    Figure 22. Product Picture of Non-small Cell Lung Cancer
    Figure 23. Product Picture of Other
    Figure 24. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Application in 2022 & 2028
    Figure 25. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Application (2017-2028)
    Figure 27. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Application in 2022 & 2028
    Figure 28. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Share by Application (2017-2028)
    Figure 30. North America Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 59. Celgene Corporation Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 60. Hospira Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 61. Biological E. Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 62. Taj Accura Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 63. Khandelwal Laboratories Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 64. Luye Pharma Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 65. Beijing Youcare Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 66. Beijing Union Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 67. Haiyao Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 68. Chuntch Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 69. Hengrui Medicine Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 70. Sanofi Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 71. Qilu Pharma Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 72. Shenzhen Main Luck Pharma Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 73. Jiangsu Aosaikang Pharma Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 74. CSPC Pharmaceutical Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 75. Aosaikang Pharm Revenue Growth Rate in Paclitaxel and Its Analogue in Anticarcinoma Drugs Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed